259 related articles for article (PubMed ID: 16879206)
21. Management of adult patients with persistent idiopathic thrombocytopenic purpura following splenectomy: a systematic review.
Vesely SK; Perdue JJ; Rizvi MA; Terrell DR; George JN
Ann Intern Med; 2004 Jan; 140(2):112-20. PubMed ID: 14734334
[TBL] [Abstract][Full Text] [Related]
22. Management of adult idiopathic thrombocytopenic purpura.
Cines DB; McMillan R
Annu Rev Med; 2005; 56():425-42. PubMed ID: 15660520
[TBL] [Abstract][Full Text] [Related]
23. Rituximab efficacy and safety in adult splenectomy candidates with chronic immune thrombocytopenic purpura: results of a prospective multicenter phase 2 study.
Godeau B; Porcher R; Fain O; Lefrère F; Fenaux P; Cheze S; Vekhoff A; Chauveheid MP; Stirnemann J; Galicier L; Bourgeois E; Haiat S; Varet B; Leporrier M; Papo T; Khellaf M; Michel M; Bierling P
Blood; 2008 Aug; 112(4):999-1004. PubMed ID: 18463354
[TBL] [Abstract][Full Text] [Related]
24. Low rate of long-lasting remissions after successful treatment of immune thrombocytopenic purpura with rituximab.
Schweizer C; Reu FJ; Ho AD; Hensel M
Ann Hematol; 2007 Oct; 86(10):711-7. PubMed ID: 17622529
[TBL] [Abstract][Full Text] [Related]
25. Immune thrombocytopenic purpura presenting in a patient after renal transplant for diabetic nephropathy.
Rashid RM; Nabi Z; Ansari AZ; Qaiser QA
BMC Nephrol; 2018 Mar; 19(1):69. PubMed ID: 29554892
[TBL] [Abstract][Full Text] [Related]
26. Canine idiopathic thrombocytopenic purpura.
Lewis DC; Meyers KM
J Vet Intern Med; 1996; 10(4):207-18. PubMed ID: 8819045
[TBL] [Abstract][Full Text] [Related]
27. Positioning new treatments in the management of immune thrombocytopenia.
Arnold DM
Pediatr Blood Cancer; 2013; 60 Suppl 1(Suppl 1):S19-22. PubMed ID: 23109488
[TBL] [Abstract][Full Text] [Related]
28. Is splenectomy necessary for immune thrombocytopenic purpura? The role of rituximab in patients with corticosteroid resistance in a single-center experience.
Zhang C; Liu HF; Chen XH; Gao L; Gao L; Liu Y; Kong PY; Sun AH; Zhang X
Clin Ther; 2014 Mar; 36(3):385-8. PubMed ID: 24594069
[TBL] [Abstract][Full Text] [Related]
29. [New treatment methods for autoimmune thrombocytopenia].
Koene HR
Ned Tijdschr Geneeskd; 2007 Nov; 151(47):2609-14. PubMed ID: 18161261
[TBL] [Abstract][Full Text] [Related]
30. Autoimmune thrombocytopenia.
Chong BH; Ho SJ
J Thromb Haemost; 2005 Aug; 3(8):1763-72. PubMed ID: 16102043
[TBL] [Abstract][Full Text] [Related]
31. Consensus Paper-ICIS Expert Meeting Basel 2009 treatment milestones in immune thrombocytopenia.
Tamary H; Roganovic J; Chitlur M; Nugent DJ
Ann Hematol; 2010 Jul; 89 Suppl 1(Suppl 1):5-10. PubMed ID: 20358200
[TBL] [Abstract][Full Text] [Related]
32. Monoclonal antibodies in the treatment of immune thrombocytopenic purpura (ITP).
Gómez-Almaguer D
Hematology; 2012 Apr; 17 Suppl 1():S25-7. PubMed ID: 22507772
[TBL] [Abstract][Full Text] [Related]
33. [Prediction of the splenectomy efficacy in chronic immune thrombocytopenic purpura].
Todorović-Tirnanić M; Obradović V; Rolović Z; Suvajdzić N; Elezović I; Colović M; Pavlović S; Bosnjaković V
Glas Srp Akad Nauka Med; 2005; (48):119-35. PubMed ID: 16405235
[TBL] [Abstract][Full Text] [Related]
34. How we treat primary immune thrombocytopenia in adults.
Liu XG; Hou Y; Hou M
J Hematol Oncol; 2023 Jan; 16(1):4. PubMed ID: 36658588
[TBL] [Abstract][Full Text] [Related]
35. Rituximab in the management of chronic immune thrombocytopenic purpura: an effective and safe therapeutic alternative in refractory patients.
Peñalver FJ; Jiménez-Yuste V; Almagro M; Alvarez-Larrán A; Rodríguez L; Casado M; Gallur L; Giraldo P; Hernández R; Menor D; Rodríguez MJ; Caballero D; González R; Mayans J; Millán I; Cabrera JR;
Ann Hematol; 2006 Jun; 85(6):400-6. PubMed ID: 16550390
[TBL] [Abstract][Full Text] [Related]
36. Immune thrombocytopenia: no longer 'idiopathic'.
McCrae K
Cleve Clin J Med; 2011 Jun; 78(6):358-73. PubMed ID: 21632906
[TBL] [Abstract][Full Text] [Related]
37. [Current treatment of primary immune thrombocytopenia].
Lozano ML; Vicente V
Med Clin (Barc); 2014 May; 142(9):399-405. PubMed ID: 23809409
[TBL] [Abstract][Full Text] [Related]
38. Idiopathic thrombocytopenic purpura: current concepts in pathophysiology and management.
Stasi R; Evangelista ML; Stipa E; Buccisano F; Venditti A; Amadori S
Thromb Haemost; 2008 Jan; 99(1):4-13. PubMed ID: 18217129
[TBL] [Abstract][Full Text] [Related]
39. Platelet kinetic study in patients with idiopathic thrombocytopenic purpura (ITP) refractory or relapsing after corticosteroid treatment.
Rossi G; Cattaneo C; Motta M; Pizzocaro C; Lanzi S; Pouchè A
Hematol J; 2002; 3(3):148-52. PubMed ID: 12111651
[TBL] [Abstract][Full Text] [Related]
40. [Treatment of idiopathic thrombocytopenic purpura in adults].
Godeau B; Bierling P
Presse Med; 2008 Sep; 37(9):1292-8. PubMed ID: 18644317
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
